Charles River Laboratories International (CRL) Revenue — Quarter Ended Sep 28, 2024
Revenue for the quarter declined compared to both the prior quarter and the same quarter last year. The decrease was consistent with the trend observed in recent quarters.
Key takeaway
Quarter ended Sep 28, 2024 · FY2024 Q3
Revenue for the quarter declined compared to both the prior quarter and the same quarter last year. The decrease was consistent with the trend observed in recent quarters.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1B
Revenue reported for this quarter.
Quarter-over-quarter
-1.6%
Change from the immediately preceding quarter.
Year-over-year
-1.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 30, 2023 | $1B | -7.9% |
| Mar 30, 2024 | $1B | -1.7% |
| Jun 29, 2024 | $1B | -3.2% |
| Sep 28, 2024 | $1B | -1.6% |
Revenue performance
Reported revenue decreased from the immediately preceding quarter, continuing a pattern of sequential declines.
Quarterly comparison
Compared to the same quarter one year earlier, revenue also declined, matching the rate of the sequential drop.
What to watch
The filing notes forward-looking statements regarding non-human primate supply chain risks and related investigations.